{"id":"W3094840453","doi":"10.1182/blood-2020-136162","title":"BCR-ABL1 Transcript Doubling Time after Imatinib Discontinuation for Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase: Predictor for Treatment-Free Remission Failure","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; McGill University Health Centre; London Health Sciences Centre; Juravinski Cancer Centre; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; CancerCare Manitoba; University of Alberta Hospital; Ottawa Hospital; University Health Network; University of Toronto; Alberta Hospital Edmonton; University of British Columbia","funders":"","keywords":"Discontinuation; Medicine; Imatinib; Myeloid leukemia; Internal medicine; Imatinib mesylate; Immunology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000968997,0.0002164673,0.0002755414,0.0003994851,0.0002736463,0.0004006552,0.0002244949,0.0002887385,0.001248812],"category_scores_gemma":[0.001746308,0.00008466511,0.0003020672,0.0004885605,0.0001821054,0.0002482216,0.0002239094,0.0005567162,0.0001895982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003969862,"about_ca_system_score_gemma":0.0003449714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009919112,"about_ca_topic_score_gemma":0.002066773,"domain_scores_codex":[0.9996758,0.00006514748,0.00004159358,0.00006677934,0.0000846432,0.00006615384],"domain_scores_gemma":[0.9970859,0.0006961447,0.001606836,0.00009108149,0.0001759579,0.0003441384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001424655,0.00004924061,0.9908382,0.00002425889,0.00002982529,0.00005792264,0.00002616032,0.0001612122,0.001237169,0.00001588516,0.0001758282,0.005959603],"study_design_scores_gemma":[0.00003049984,0.0004294101,0.9971828,0.0000121171,0.0000482046,0.0004578847,0.00002788432,0.000592646,0.0006121275,0.00003331077,0.0005683458,0.000004739138],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980285,0.0008403255,0.0002035077,0.00004173443,0.000005846324,0.00001626893,0.0004757772,0.000006632998,0.0003813985],"genre_scores_gemma":[0.9991097,0.0001087812,0.0001515585,0.00001886735,0.00001005398,0.00001538389,0.0004621638,0.000002070625,0.0001215164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001248812,"threshold_uncertainty_score":0.005124569,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02419756276981712,"score_gpt":0.2879381381525468,"score_spread":0.2637405753827297,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}